tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: MDxHealth S.A. Sponsored ADR (MDXH) and Morphic Holding (MORF)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on MDxHealth S.A. Sponsored ADR (MDXHResearch Report) and Morphic Holding (MORFResearch Report) with bullish sentiments.

MDxHealth S.A. Sponsored ADR (MDXH)

BTIG analyst Mark Massaro reiterated a Buy rating on MDxHealth S.A. Sponsored ADR on August 3 and set a price target of $13.00. The company’s shares closed last Thursday at $7.85.

According to TipRanks.com, Massaro is a 3-star analyst with an average return of 0.9% and a 45.7% success rate. Massaro covers the Healthcare sector, focusing on stocks such as Ginkgo Bioworks Holdings, Adaptive Biotechnologies, and Castle Biosciences.

MDxHealth S.A. Sponsored ADR has an analyst consensus of Moderate Buy, with a price target consensus of $15.50.

See today’s best-performing stocks on TipRanks >>

Morphic Holding (MORF)

BTIG analyst Julian Harrison maintained a Buy rating on Morphic Holding on August 3 and set a price target of $64.00. The company’s shares closed last Thursday at $31.93.

According to TipRanks.com, Harrison has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -13.2% and a 37.5% success rate. Harrison covers the Healthcare sector, focusing on stocks such as Prometheus Biosciences, Liquidia Technologies, and United Therapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Morphic Holding with a $64.09 average price target, which is a 120.2% upside from current levels. In a report issued on July 20, SVB Securities also initiated coverage with a Buy rating on the stock with a $45.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on MDXH:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed